Unassociated Document
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549

 
FORM 8-K


CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934


Date of Report (Date of earliest event reported): August 9, 2004

HALSEY DRUG CO., INC.


616 N. North Court, Suite 120, Palatine, Illinois 60067
(847-705-7709)

 Incorporated under the laws of
State of New York

 Commission File Number
1-10113

 I.R.S. Employer Identification Number
11-0853640

 
 
     
 
 
Item 12. Results of Operations and Financial Condition

On August 9, 2004, Halsey Drug Co., Inc. (the "Company") issued a press release disclosing the financial results for its second quarter ended June 30, 2004 and the six months ended June 30, 2004. A copy of the Company's press release is attached as Exhibit 99.1 hereto.

Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.

(b)   Exhibits

Exhibit
Number        Description
99.1       Press Release dated August 9, 2004 Announcing Results for Second Quarter ended June 30, 2003

 
     
 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
     
  HALSEY DRUG CO., INC.
 
 		  
 		  
 
Date: August 9, 2004 By:   /s/ Peter A. Clemens
 
Peter A. Clemens
  Senior Vice President & Chief Financial Officer

 
 
 
     
 
EXHIBIT INDEX

Exhibit
Number       Description
99.1          Press Release dated August 9, 2004 Announcing Results for Second Quarter ended June 30, 2004.